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Ascaridiasis as a Risk Factor for Anemia 
in a Special Immunocompromised Host: 
The Pregnant Women 
A.J. Rodriguez-MoraLes*, R.A. BarbeLLa, C. Case, 
M. Arria, M. Rave[o, VenezueLan CoLLaborative 
Research Group of Tropical Diseases in Pregnancy. 
Center for Parasitological Research JW-I~, Los 
Andes University, Trujillo, Venezuela 
Background: From many points of view, the preg- 
nant woman could be considered as a temporarily 
immunocompromised host due to immunosuppres- 
sive processes that prevent fetal rejection in utero. 
The increased susceptibility of pregnant women 
to different infections has Long been recognized, 
but the magnitude of some diseases burden in this 
particular group, have only recently been the focus 
of research. Some of them are the tropical diseases 
such as infections due to heLminths. 
Objectives: We were interested on study the aeti- 
oLogica[ agents producing intestinal parasitosis as 
weLL their effects on cLinicaL and hematoLogicaL 
parameters, in a cohort of asymptomatic pregnant 
women Living in endemic areas of VenezueLa. 
Methods: During 24 months, 1175 pregnant women 
attending 20 antenatal care centers from 10 states 
were included and evaluated. Routine prenatal 
controL, physical examination and Laboratory stud- 
ies were performed (CBC, seroLogicaL screening for 
HIV, HBV, SyphiLis and ToxopLasmosis). Copropara- 
sitoLogica[ studies aLL women were done. Different 
stools examinations were used in detecting para- 
sites. Uni- and muLtivariated analyses were made 
to assess risk factors. ALL data were analyzed with 
SPSS 10.0 at 95% confidence. 
Results: Mean age and gestationa[ age were 
23.24-6.1 y-oLd and 29.94-3.8 weeks. Anemia was 
observed in 68.3% of woman, and eosinophiLia 
in 25.1%. Intestinal parasitosis was seen in 
899 women (76.5%). From this totaL, 62.7% corre- 
sponded to Ascaris lumbricoides, 37.4% to Trichuris 
trichium, 22.55% to Giardia lamblia, among oth- 
ers; 50.7% presented infections due to two-four 
different parasite species. Anemia was signifi- 
cantLy higher in A. lumbricoides infected women 
(89.9% vs. 31.9% in non-infected). ReLative risk of 
anemia in women infected with A. lumbricoides 
was 2.81 (95%CI 2.45-3.23) (p<0.001). ReLative 
eosinophiLs and relative [ymphocytes counts were 
significantly higher in those infected compared 
with those woman non-infected. 
Conclusions: Anemia has been frequently reported 
for other heLminthes (i.e. hookworms) but rarely 
for A. lumbricoides which can be tissue dweLLing 
or intestinal and induce a dramatic expansion of 
the Th2 Lymphocyte subset. It remains unclear 
whether these Th2-derived responses, including 
IgE, eosinophiLia and mastocytosis are important in 
the protective immune response to the parasite, or 
are responsible for immune-mediated pathology, or 
both. The implications of these results should be 
further studied and defined. 
74 
Antifungal Prophylaxis is Effective against 
Murine Invasive Pulmonary Asper~illosis 
G. Rieg, B.J. SpeLLberg, J. Schwartz, Y. Fu, 
J.E. Edwards Jr., D.C. Sheppard, A.S. Ibrahim* 
Los Angeles Biomedical Research and Institute at 
Harbor-UCLA, Medical Center Torrance, CA 90502, 
USA 
Background: Antifunga[ prophylaxis is a promising 
strategy to prevent and/or ameliorate invasive puL- 
monary aspergillosis (IPA). Concerns have arisen 
over the use of prophylactic voriconazoLe, so aL- 
ternative antifungaL strategies merit exploration. 
In particular, Lipid amphotericin formulations are 
promising prophylactic agents because they accu- 
muLate in tissues, and thus may not require daily 
administration to mediate protection against the 
smaLL numbers of inhaled conidia initiating infec- 
tion. 
Methods: BALB/c mice with cydophosphamide/ 
cortisone acetate-induced immunosuppression were 
infected via inhalation with A. fumigatus. Mice 
were treated iv prior to infection with AmBisome 
(LAMB), AbeLcet (ABLC), amphotericin B (AmB), 
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or caspofungin acetate (CAS). Endpoints were sur- 
vival, colony forming units (CFUs), and histology of 
lungs. 
Results: Initially, we compared the efficacy of a 
single dose of LAmB at 15 mg/kg to a dual treat- 
ment close of 7.5mg/kg given every other day. 
The single 15mg/kg close and the second of the 
dual 7.5 mg/kg doses were administered 24, 48 or 
72 hours prior to infection. Only administration of 
dual 7.5 mg/kg doses of LAmB at 24 or 48 h prior to 
infection resulted in equivalent, significant protec- 
tion as compared to placebo (100% vs 50%, p <0.05). 
This data indicated that the total amount of LAmB 
administered over time was more important han 
the individual amount of each dose. Next, we com- 
pared dual doses of LAmB at 7.5 mg/kg with ABLC 
at 7.5 mg/kg, AmB at 1 mg/kg, and CAS at 1 mg/kg 
given on days -4 and -2 prior to infection. Addi- 
tionally, CAS was also administered as a single dose 
6 hours prior to infection. Only LAmB and the single 
dose arm of CAS significantly improved survival 
compared to placebo (75% and 88% vs 25% survival 
of placebo, p < 0.04). Lung CFUs was significantly 
reduced by prophylactic administration of LAmB 
(p=0.005), AmB (p=0.03), or CAS (given 6 h prior 
to infection, p=0.0002) but not ABLC. These re- 
suits were mirrored in histopatho[ogica[ evaluation 
since lungs from mice receiving placebo and ABLC 
revealed large amounts of elongated hyphae with 
moderate necrotizing pneumonia, whereas lungs of 
mice treated with LAMB, AmB, or CAS did not. 
Conclusions: These data indicate that LAmB ad- 
ministered aily or every other day is a promising 
candidate for prophylaxis against pulmonary as- 
pergillosis in neutropenic hosts. CAS also mediates 
prophylactic effect, but must be dosed more often 
than LAmB for efficacy. 
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Mouse Models for the Evaluation of Antiviral and 
Immunotherapy in the Treatment of Systemic 
Adenovirus Infections 
L. Lenaerts*, E. De C[ercq, E. Verbeken, 
L. Naesens. Rega Institute [or Medical Research, 
Katholieke Universiteit Leuven, B-3000 Leuven, 
Belgium 
Background: Severe adenovirus infections are of 
increasing concern in AIDS patients and trans- 
plant recipients under immunosuppressive th rapy. 
Unfortunately, current therapeutic moda[ities for 
adenovirus infections are limited. 
Objectives: We investigated the contribution of 
the host's adaptive immune response and the ef- 
ficacy of immunotherapy in the control of systemic 
adenovirus infections using two mouse models. 
Methods ~ Results: Severe combined immune 
deficient (SClD) mice, intranasa[[y inoculated with 
mouse adenovirus type 1 (MAV-1), develop a fa- 
tal disseminated isease characterized by hem- 
orrhagic enteritis (Lenaerts et aL, 2005, Antimi- 
crob Agents Chemother 49, 4689-99). When SCID 
mice were treated with antisera containing MAV-1 
specific IgG, MAV-l-induced death was significantly 
delayed from day 18 p.i. (untreated mice) to day 
42-60 p.i. (antiserum-treated mice). The extent of 
the delay was dependent on the titer of MAV-1 neu- 
tralizing antibodies in the antiserum. The MAV-1 
antisera were obtained from immunocompetent 
mice challenged with MAV-1 and were transferred 
to the MAV-l-infected SCID mice at day -1 and 
day 9 post infection. Ultimately, MAV-l-infected 
SCID mice treated with the MAV-l-antisera showed 
100% mortality, with identical pathology and simi- 
lar virus titers in the target organs as seen in un- 
treated, infected SCID mice. These results indicate 
that antibodies play a major role in protection and 
elimination of systemic adenovirus infection. In an 
alternative mouse mode[ for adenovirus infection, 
cyc[ophosphamide (CY) was administered to adult 
BALB/c mice to induce a genera[ and reversible 
immunosuppression. MAV-l-re[ated mortality cor- 
related with the duration of immunosuppressive 
therapy. Mice receiving CY for 3 or more weeks 
succumbed to an identical pathology and similar 
virus titers in the affected tissues as seen with 
MAV-l-infected SCID mice. On the contrary, mice 
in which immunosuppressive therapy was ceased 
1 week post infection did not develop symptoms 
and survived. These mice showed high serum titers 
(~>1:160) of MAV-1 neutralizing antibodies. Studies 
are ongoing to evaluate the efficacy of antivira[s 
(such as cidofovir) in this MAV-1/CY mode[. 
Conclusions: These two new mouse models wi[[ in- 
crease our understanding of the suppression of ade- 
novirus disease by antivira[ and/or immunotherapy 
and wi[[ be helpful in the development of an ade- 
quate treatment for systemic adenovirus infections 
in immunocompromised patients. 
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Strategy of Vaccination Against HBV-infection in 
Hemodialysis Patients with 'Isolated' HBcAb 
M. Zubkin*, E. Ba[akirev, V. Chervinko, F. Baranova, 
V. Taranov, I. Baku[in, A. Stanke, V. Novozhenov. 
State Postgraduate Medical Institute o[ De[ence 
Ministry, Nephrological Center, Moscow, Russian 
Federation 
Background: Advisability of vaccination against the 
HBV infection in patients with 'isolated' HBcAb 
